How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
RXRX is trading near the bottom of its 52-week range and below its 200-day simple moving average. Price change The price of RXRX shares has increased $0.13 since the market last closed. This is a 3.83 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results